Causes of Treatment Failure for PSC-MEC Induction Therapy in Poor-Risk AML Patients in This Study
| . | Cohort I . | Cohort II . | Total . |
|---|---|---|---|
| Death during hypoplasia | |||
| Infection | 3 | 6 | 9 |
| Arrhythmia | 0 | 14-150 | 1 |
| Myocardial infarction | 0 | 14-151 | 1 |
| Hemorrhage | 0 | 1‡ | 1 |
| Leukemia-associated | |||
| Regrowth resistance | 1 | 7 | 8 |
| Refractory | 0 | 1 | 1 |
| Total | 4 | 17 | 21 |
| . | Cohort I . | Cohort II . | Total . |
|---|---|---|---|
| Death during hypoplasia | |||
| Infection | 3 | 6 | 9 |
| Arrhythmia | 0 | 14-150 | 1 |
| Myocardial infarction | 0 | 14-151 | 1 |
| Hemorrhage | 0 | 1‡ | 1 |
| Leukemia-associated | |||
| Regrowth resistance | 1 | 7 | 8 |
| Refractory | 0 | 1 | 1 |
| Total | 4 | 17 | 21 |